US equities |
MU $1,071.58 ▲+2.49% NVDA $237.39 ▼-0.77% SNDK $1,712.56 ▲+3.14% AMD $644.41 ▼-0.77% INTC $113.83 ▲+1.18% SPCX $169.34 ▼-1.50% TSLA $375.87 ▼-1.26% AAPL $335.57 ▲+0.58%
FinancialContent

Latest News about Jason Gerberry

Recent news which mentions Jason Gerberry

Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
Tickers XENE
Tags Benzinga Jason Gerberry Initiation
From Benzinga
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
Tickers TEVA
Tags Upgrades Benzinga Jason Gerberry
From Benzinga
Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical
Tickers AXSM
Tags FDA Market News News
From Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
Tickers TEVA
Tags Analyst Ratings Health Care Upgrades
From Benzinga
BofA Initiates Arcellx With Buy On Its Novel Therapy Approach
Tickers ACLX
Tags Small Cap Analyst Ratings Market News
From Benzinga
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
Tickers IONS
Tags Jason Gerberry Analyst Color BofA Securities
From Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
Tickers ALKS
Tags Jason Gerberry ALKS BofA Securities
From Benzinga
FibroGen Analyst Removes Roxadustat Sales From Model After AdCom Snub
Tickers FGEN
Tags Benzinga FGEN Movers
From Benzinga